Down-regulation of CD3zeta is a breast cancer biomarker associated with immune suppression
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Estimation of the Youden Index and its Associated Cutoff Point
2005 • 2,141 citations
Understanding diagnostic tests 3: receiver operating characteristic curves
2007 • 1,698 citations
Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples
2004 • 1,059 citations
<scp>l</scp>-Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes
2003 • 458 citations
The Youden Index and the Optimal Cut‐Point Corrected for Measurement Error
2005 • 246 citations
l-Arginine modulates CD3ζ expression and T cell function in activated human T lymphocytes
2004 • 200 citations
Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.
1998 • 147 citations
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays
2008 • 116 citations
Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations
2006 • 115 citations
Helicobacter pylori Arginase Inhibits T Cell Proliferation and Reduces the Expression of the TCR ζ-Chain (CD3ζ)
2004 • 114 citations
Use of High-Throughput Protein Array for Profiling of Differentially Expressed Proteins in Normal and Malignant Breast Tissue
2004 • 101 citations
Antibody arrays—An emerging tool in cancer proteomics
2007 • 78 citations
Human TCR That Incorporate CD3ζ Induce Highly Preferred Pairing between TCRα and β Chains following Gene Transfer
2008 • 77 citations
Loss of heterozygosity on chromosome arm 16q in breast cancer metastases
1997 • 76 citations
Decreased Expression of CD3ζ and Nuclear Transcription Factor κB in Patients with Pulmonary Tuberculosis: Potential Mechanisms and Reversibility with Treatment
2006 • 71 citations
IPO-38 Is Identified as a Novel Serum Biomarker of Gastric Cancer Based on Clinical Proteomics Technology
2008 • 52 citations
Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers
2000 • 50 citations
Down-regulation of CD28, TCR-zeta (zeta) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients.
2008 • 44 citations
Decreased Expression of ζ Molecules by T Lymphocytes Is Correlated with Disease Progression in Human Immunodeficiency Virus–Infected Persons
1999 • 38 citations
Loss of T-cell receptor-CD3ζ and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma
2001 • 35 citations
Down-regulation of the CD3-ζ chain in sentinel node biopsies from breast cancer patients
2002 • 33 citations
CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-zeta chain expression.
2004 • 29 citations
Proteomic Analysis of Autocrine/Paracrine Effects of Human Growth Hormone in Human Mammary Carcinoma Cells
2008 • 15 citations
Association between the expression of IL-10 and T cell activation proteins loss in early breast cancer patients
2008 • 10 citations
Immunobiological Characterization of N-Nitrosomethylurea-Induced Rat Breast Carcinomas: Tumoral IL-10 Expression as a Possible Immune Escape Mechanism
2004 • 9 citations
Evaluation of the Predictive Performance of Nutritional Indicators by Receiver‐Operating Characteristic Curve Analysis
1991 • 8 citations
Defective CD3ζ chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma
2005 • 6 citations
Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier
2007 • 5 citations
Cited By (0)
No citing papers found in database